ASCVD risk increases with age, with individuals over 40 being at higher risk than younger age groups, putting men at a relatively higher risk than women. However, after menopause, the risk for women increases and eventually equals that of men.
Study
Take Part in Atherosclerosis Research
(Hardening of the Arteries)
- Age: 40 to 79 Years Old
- Gender: All
- Condition: Atherosclerotic Coronary Artery Disorder
- Status: Active
Cardiovascular Clinical Trials are underway in Little River, South Carolina, to help people with ASCVD manage and reduce the risks associated with the disease.
About Cardiovascular Disorders
Atherosclerotic cardiovascular disease (ASCVD) is a condition where fat buildup in arteries, makes them narrow, reducing blood flow and raising the risk of heart attack, stroke, and other cardiovascular problems.
High blood pressure and elevated levels of LDL cholesterol are the two primary causes of atherosclerotic cardiovascular disease (ASCVD). High blood pressure can damage arteries over time, while high LDL cholesterol can lead to plaque buildup in arteries.
Contact Us
Submit A Request
Still have questions?
Frequently Asked
Questions
How long does Atherosclerosis Research last?
The study will last between 6 to 7 years.
What is the location of the Cardiovascular Research Study?
Little River Institute is currently Cardiovascular Clinical Trials in South Carolina. If you are interested in participating in the research study, contact us via the form.
Will I receive the placebo or the actual study drug?
In this double-blind, placebo-controlled study, participants may be randomly assigned to either the placebo group or the investigational drug group, known as the control group.
What causes Atherosclerotic Calcification?
Atherosclerotic calcification is caused by the narrowing of heart arteries due to plaque buildup, primarily made of cholesterol and fat. This calcification process involves the hardening of these plaque deposits in the arteries